{
    "organizations": [],
    "uuid": "6d5a4850a378e5eb7a95059c1ca671c6d38378b6",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-eyegate-submits-investigational-de/brief-eyegate-submits-investigational-device-exemption-amendment-for-ocular-bandage-gel-idUSASC0A37Y",
    "ord_in_thread": 0,
    "title": "BRIEF-EyeGate Submits Investigational Device Exemption Amendment For Ocular Bandage Gel",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 22 (Reuters) - EyeGate Pharmaceuticals Inc:\n* EYEGATE ADDRESSES MAJORITY OF FDA’S ACTION ITEMS WITH SUBMISSION OF INVESTIGATIONAL DEVICE EXEMPTION AMENDMENT FOR OCULAR BANDAGE GEL\n* EYEGATE PHARMACEUTICALS INC - RESPONSE TO FOURTH ACTION ITEM EXPECTED IN Q2 OF 2018 WITH POTENTIAL TO START CLINICAL STUDY IN Q3 OF 2018\n* EYEGATE PHARMACEUTICALS INC - WORK CONTINUES ON FILTER VALIDATION REQUIREMENT ASSOCIATED WITH EYEGATE OBG PRODUCT\n* EYEGATE PHARMACEUTICALS - ADDRESSED THREE OF FOUR OUTSTANDING ITEMS IN SECOND AMENDMENT IN RESPONSE TO U.S. FDA’S REVIEW OF FIRST AMENDMENT Source text for Eikon: Further company coverage:\n ",
    "published": "2018-05-22T20:45:00.000+03:00",
    "crawled": "2018-05-23T15:14:44.023+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "eyegate",
        "pharmaceutical",
        "inc",
        "eyegate",
        "address",
        "majority",
        "fda",
        "action",
        "item",
        "submission",
        "investigational",
        "device",
        "exemption",
        "amendment",
        "ocular",
        "bandage",
        "gel",
        "eyegate",
        "pharmaceutical",
        "inc",
        "response",
        "fourth",
        "action",
        "item",
        "expected",
        "q2",
        "potential",
        "start",
        "clinical",
        "study",
        "q3",
        "eyegate",
        "pharmaceutical",
        "inc",
        "work",
        "continues",
        "filter",
        "validation",
        "requirement",
        "associated",
        "eyegate",
        "obg",
        "product",
        "eyegate",
        "pharmaceutical",
        "addressed",
        "three",
        "four",
        "outstanding",
        "item",
        "second",
        "amendment",
        "response",
        "fda",
        "review",
        "first",
        "amendment",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}